Gilead Opens 182,000-Square-Foot Research Center in Foster City

Editor’s Take: This move is part of Gilead’s broader $32 billion investment in the United States.

Gilead Sciences Inc. has opened a 182,000-square-foot Research Center at its Foster City headquarters, expanding capabilities in oncology, inflammation and research data science.

Gilead marked the milestone with a ribbon-cutting ceremony attended by company leaders, scientists and government and community guests.

“We are in a moment of unprecedented opportunity in science and technology. Our new Research Center will help Gilead scientists make the most of that opportunity, delivering more breakthrough medicines faster,” said Daniel O’Day, Chairman and CEO, Gilead Sciences. “As part of our broader $32 billion investment in the United States, this new facility also reflects our long-term commitment to American innovation.”

Designed with input from Gilead research colleagues, the five-story center will support approximately 325 employees, including 260 laboratory scientists. Flexible laboratory neighborhoods, specialized collaboration spaces and shared technology platforms will enable teams to adapt as scientific needs evolve. All-electric systems, energy-efficient design and water-saving landscaping featuring California native plants are expected to support LEED Gold certification.

The Research Center is one of three major Foster City projects advancing Gilead’s broader U.S. investment in research, development and manufacturing through 2030. The Technical Development Center, expected to open in 2027, and the biologics facility, which broke ground in August and is expected to open in 2029, will further strengthen Gilead’s U.S. research and development infrastructure.